Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients
- 27 January 2021
- journal article
- letter
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 43 (4), E152-E155
- https://doi.org/10.1111/ijlh.13476
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2International Journal of Laboratory Hematology, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19The New England Journal of Medicine, 2020
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory FailureCell Host & Microbe, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- ChangesJournal of Thrombosis and Haemostasis, 2020
- Variation of endothelium‐related hemostatic factors during sepsisMicrocirculation, 2018
- Inflammation, von Willebrand factor, and ADAMTS13Blood, 2018
- The role of ADAMTS‐13 in the coagulopathy of sepsisJournal of Thrombosis and Haemostasis, 2018